View Older Stories View More Recent Stories
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Synovus Financial (SNV) PT Lowered to $62 at Citi
-
Investors see IMF support as crucial for Bolivia's new president
-
Mineros Announces Investor Meetings for Senior Notes
-
Chief Appoints Roshanie Ross as Chief Experience Officer, a Customer-Obsessed Leader Driving Innovation Across the Member Journey
-
Shopify (SHOP): Citizens Sees Agentic Commerce Growth Driver, Reiterates at Market Outperform
-
U.S. Physical Therapy (USPH): Citizens Sees Strong Growth Outlook, Reiterates at Outperform
-
Citizens Highlights Summit’s (SMMT) Ivonescimab Superiority, Reiterates at Outperform
-
Citizens Highlights Kura Oncology’s (KURA) KO-2806 Potential, Reiterates at Outperform
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Truist hires energy and technology banking heads from Citi and JPMorgan
-
Truist hires Corporate Banking leaders for energy and technology sectors
-
US Financial 15 Split Corp. declares monthly dividend of $0.07083
-
US Financial 15 Split Corp. Preferred Dividend Declared
-
Financial 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share
-
North American Financial 15 Split Corp Monthly Dividend Declaration for Class A & Preferred Share
-
Citius Oncology signs distribution deal with McKesson for LYMPHIR launch
-
Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch
-
Evernorth to go public via SPAC merger raising over $1 billion


